Home / News / India News / Article /
Covid-19: Centre to rethink precaution dose policy
Updated On: 28 January, 2022 03:46 PM IST | New Delhi | PTI
The National Technical Advisory Group on Immunisation (NTAGI) for Covid-19 held a high level meeting with NITI Aayog on January 26. A source said that the NTAGI group is sceptical about the benefits of the third dose being administered
Listen to this article :
This picture has been used for representational purpose
The Centre is mulling over the relevance of the precaution dose which is currently being administered to the frontline and healthcare workers along with 60 plus population as some experts are sceptical about the benefits of the third dose.
The National Technical Advisory Group on Immunisation (NTAGI) for Covid-19 held a high level meeting with NITI Aayog on January 26. A source said that the NTAGI group is sceptical about the benefits of the third dose being administered.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT